SCHEMBL5565941

SCHEMBL5565941

O=CC(=O)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL809080 0.70
SCHEMBL688566 0.70
SCHEMBL10600007 0.70
SCHEMBL809089 0.70
SCHEMBL1726945 0.67
SCHEMBL124775 0.67
SCHEMBL830469 0.67
SCHEMBL122037 0.65
SCHEMBL11235276 0.64
Glyoxylate SCHEMBL1518069 0.63 TSHR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105658639-A Alkynyl alcohols and methods of use 豪夫迈·罗氏有限公司 2016-06-08 CN disclosed
CN-105339368-A 3-aryl-substituted imidazo[1,2-a]pyridines and the use thereof Bayer Pharma AG 2016-02-17 CN disclosed
CN-103508930-B Two (aminodithioformic acid)-1,3-propylene diester compounds and synthetic method, pharmaceutical composition and purposes PEKING UNIVERSITY (CN) 2016-01-27 CN disclosed
CN-104981472-A Heteroaromatic compounds and their use as dopamine d1 ligands PFIZER 2015-10-14 CN disclosed
CN-104981470-A Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use Bayer Pharma AG 2015-10-14 CN disclosed
CN-104955823-A Carboxy-substituted imidazo [1,2-a ] pyridinecarboxamides and their use as stimulators of soluble guanylate cyclase Bayer Pharma AG 2015-09-30 CN disclosed
CN-104918945-A Tricyclic fused thiophene derivatives as JAK inhibitors INCYTE CORP 2015-09-16 CN disclosed
CN-104781258-A Hydroxy-substituted imidazo [1,2-a ] pyridinecarboxamides and their use as soluble guanylate cyclase stimulators Bayer Pharma AG 2015-07-15 CN disclosed
CN-104619709-A Imidazopyridine derivatives as modulators of TNF activity UCB PHARMA SA 2015-05-13 CN disclosed
CN-104470924-A Imidazopyrazine derivatives as modulators of tnf activity UCB PHARMA SA 2015-03-25 CN disclosed
CN-102395585-A Heteroaryls and their use as pi3k inhibitors MILLENNIUM PHARM INC 2012-03-28 CN disclosed
EP-1480976-B1 THIAZOLE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2007-09-19 EP disclosed
EP-1480976-A1 THIAZOLE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2004-12-01 EP disclosed
CN-1170822-C Imidazole compounds and pharmaceutical use thereof ����ҩƷ��ҵ��ʽ���� 2004-10-13 CN disclosed
US-6686381-B2 COMPOUNDS THAT ANTAGONIZE NEUROPEPTIDE Y AT THE Y5 RECEPTOR SUBTYPE REPRESENT AN APPROACH TO THE TREATMENT OF EATING DISORDERS SUCH AS OBESITY AND HYPERPHAGIA HOFFMANN-LA ROCHE INC. 2004-02-03 US disclosed
US-20030225141-A1 THIAZOLE DERIVATIVES HOFFMANN-LA ROCHE INC. 2003-12-04 US disclosed
WO-2003072577-A1 THIAZOLE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2003-09-04 WO disclosed
CN-1335837-A Imidazole compounds and medicinal use thereof FUJISAWA PHARMACEUTICAL CO (JP) 2002-02-13 CN disclosed
CN-1268942-A Sulfonamide compounds and medicinal use thereof FUJISAWA PHARMACEUTICAL CO (JP) 2000-10-04 CN disclosed
CN-1020608-C Preparation of 5-(6-imidazo [1,2-a] pyridyl) pyridine derivative EISAI CO LTD (JP) 1993-05-12 CN disclosed